• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将特定部位的肠道微生物组和真菌微生物组分析与临床指标相结合,以有效管理儿童克罗恩病。

Combining site-specific gut microbiome and mycobiome profiling with clinical indicators for effective management of pediatric Crohn's disease.

作者信息

Kim Dongseok, Park Seo-Young, Lee Yi Qing, Kwon Yiyoung, Choe Yon Ho, Kim Mi Jin, Lee Dong-Yup

机构信息

School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea.

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

iScience. 2025 Jul 18;28(8):113160. doi: 10.1016/j.isci.2025.113160. eCollection 2025 Aug 15.

DOI:10.1016/j.isci.2025.113160
PMID:40822348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12355157/
Abstract

Pediatric-onset Crohn's disease (pCD) is characterized by frequent relapses and long-term impacts on growth, requiring targeted strategies for disease monitoring and treatment. To characterize gut microbiome and mycobiome changes in pCD, we profiled bacterial and fungal communities across multiple gastrointestinal (stool, colon, and terminal ileum) in 30 pre- and post-treatment patients and 36 healthy controls. Microbial shifts in mucosal biopsies lagged behind those in stool, indicating site-specific responsiveness to treatment. Notably, erythrocyte sedimentation rate (ESR) and the simple endoscopic score for CD (SES-CD) were strongly associated with bacterial composition, while platelet count (PLT) and body mass index (BMI) correlated with fungal compositional changes. Twelve key genera were linked to clinical indices across different sample types, with emerging as a relapse-associated biomarker. These findings highlight the importance of spatial sampling in pCD and delineate microbiota-associated genera and clinical indicators that may guide future precision diagnostics and therapeutic monitoring strategies.

摘要

儿童期发病的克罗恩病(pCD)的特点是频繁复发以及对生长产生长期影响,这需要针对性的疾病监测和治疗策略。为了明确pCD中肠道微生物组和真菌组的变化,我们对30例治疗前和治疗后的患者以及36名健康对照者的多个胃肠道部位(粪便、结肠和回肠末端)的细菌和真菌群落进行了分析。黏膜活检中的微生物变化滞后于粪便中的变化,表明对治疗存在部位特异性反应。值得注意的是,红细胞沉降率(ESR)和克罗恩病简易内镜评分(SES-CD)与细菌组成密切相关,而血小板计数(PLT)和体重指数(BMI)与真菌组成变化相关。12个关键菌属与不同样本类型的临床指标相关,其中 作为复发相关生物标志物出现。这些发现凸显了在pCD中进行空间采样的重要性,并确定了可能指导未来精准诊断和治疗监测策略的微生物相关菌属和临床指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/4fda60f776de/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/6b4d4ea7d45e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/45c266b0fde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/4a6aa73aa83e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/5fe0506e78e4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/2b9ceaf5f71e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/729ef5e7bfaf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/d4954e9b056f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/4fda60f776de/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/6b4d4ea7d45e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/45c266b0fde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/4a6aa73aa83e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/5fe0506e78e4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/2b9ceaf5f71e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/729ef5e7bfaf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/d4954e9b056f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1094/12355157/4fda60f776de/gr7.jpg

相似文献

1
Combining site-specific gut microbiome and mycobiome profiling with clinical indicators for effective management of pediatric Crohn's disease.将特定部位的肠道微生物组和真菌微生物组分析与临床指标相结合,以有效管理儿童克罗恩病。
iScience. 2025 Jul 18;28(8):113160. doi: 10.1016/j.isci.2025.113160. eCollection 2025 Aug 15.
2
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
3
Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.克罗恩病内镜缓解期、肥胖症和高遗传风险病例表现出结肠黏膜-腔界面微生物组的重叠变化。
Genome Med. 2022 Aug 15;14(1):91. doi: 10.1186/s13073-022-01099-7.
4
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.用于评估克罗恩病疾病活动度的内镜评分指标。
Cochrane Database Syst Rev. 2016 Aug 8;2016(8):CD010642. doi: 10.1002/14651858.CD010642.pub2.
5
Performance of serum gelsolin as a biomarker for mucosal activity in Crohn's disease: a comparison with C-reactive protein.血清凝溶胶蛋白作为克罗恩病黏膜活性生物标志物的性能:与C反应蛋白的比较。
Therap Adv Gastroenterol. 2025 Aug 19;18:17562848251362570. doi: 10.1177/17562848251362570. eCollection 2025.
6
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
7
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials.利用两项随机对照试验的数据开发并验证一种用于评估克罗恩病的新型内镜溃疡活动评分(EASE-CD)
Lancet Gastroenterol Hepatol. 2025 Aug;10(8):746-756. doi: 10.1016/S2468-1253(25)00093-7. Epub 2025 Jun 9.
8
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
9
Machine learning models reveal Saccharomyces yeasts are associated with poor piglet growth in early development.机器学习模型显示,酿酒酵母与仔猪早期发育阶段生长不良有关。
J Anim Sci. 2025 Jan 4;103. doi: 10.1093/jas/skaf133.
10
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.对病情缓解的克罗恩病患者停用免疫抑制剂或生物疗法。
Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2.

本文引用的文献

1
Composition, Influencing Factors, and Effects on Host Nutrient Metabolism of Fungi in Gastrointestinal Tract of Monogastric Animals.单胃动物胃肠道真菌的组成、影响因素及其对宿主营养代谢的作用
Animals (Basel). 2025 Mar 1;15(5):710. doi: 10.3390/ani15050710.
2
Multimodal metagenomic analysis reveals microbial InDels as superior biomarkers for pediatric Crohn's disease.多组学宏基因组分析揭示微生物插入缺失是儿童克罗恩病的优良生物标志物。
J Crohns Colitis. 2025 Apr 4;19(4). doi: 10.1093/ecco-jcc/jjaf039.
3
Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn's disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis.
核心微生物群的耗竭构成了克罗恩病和肠结核中不同生态失调模式的共同背景:来自综合多队列分析的见解
Gut Pathog. 2024 Nov 7;16(1):65. doi: 10.1186/s13099-024-00654-4.
4
The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses.类风湿性关节炎肠道微生物生物样本库揭示了与宿主炎症和自身免疫反应相关并产生影响的核心微生物物种。
Imeta. 2024 Oct 3;3(5):e242. doi: 10.1002/imt2.242. eCollection 2024 Oct.
5
Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease.炎症性肠病生物治疗后肠道微生物群及厚壁菌门/拟杆菌门比例的变化
J Microbiol Immunol Infect. 2025 Feb;58(1):62-69. doi: 10.1016/j.jmii.2024.09.006. Epub 2024 Oct 1.
6
Prevotella histicola ameliorates DSS-induced colitis by inhibiting IRE1α-JNK pathway of ER stress and NF-κB signaling.栖粪链球菌通过抑制内质网应激的 IRE1α-JNK 途径和 NF-κB 信号通路改善 DSS 诱导的结肠炎。
Int Immunopharmacol. 2024 Jun 30;135:112285. doi: 10.1016/j.intimp.2024.112285. Epub 2024 May 18.
7
, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil.一种能够代谢5-氟尿嘧啶的产丁酸细菌。
mSphere. 2024 Apr 23;9(4):e0081623. doi: 10.1128/msphere.00816-23. Epub 2024 Mar 12.
8
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight.人体肠道微生物群中的细菌和真菌群落之间的关联及其对营养状况和体重的影响。
Sci Rep. 2024 Mar 8;14(1):5703. doi: 10.1038/s41598-024-54782-7.
9
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease.黏膜宿主-微生物相互作用与炎症性肠病的临床表型相关。
Nat Commun. 2024 Feb 17;15(1):1470. doi: 10.1038/s41467-024-45855-2.
10
Gut microbiota signatures in inflammatory bowel disease.肠道微生物群特征与炎症性肠病。
United European Gastroenterol J. 2024 Feb;12(1):22-33. doi: 10.1002/ueg2.12485. Epub 2023 Dec 2.